Leptin can promote EMT in breast cancer cells by upregulating the expression of PKM2 and activating the PI3K/AKT signaling pathway, while antagonizing leptin receptors and the PI3K/AKT signaling pathway can block the EMT phenomenon induced by leptin, which provides a new idea for the treatment of breast cancer (26). This evidence concerns the gene LEP and breast cancer.